Key result
Cardiac magnetic resonance provides an accurate and robust complementary imaging modality to echocardiography for grading mitral regurgitation severity, assessing ventricular volumes, and identifying myocardial fibrosis.
Why the study?
Evaluating mitral regurgitation severity with first-line echocardiography can remain challenging, highlighting the growing need to outline the role of CMR in disease assessment and management.
What is the role of Cardiovascular Magnetic Resonance (CMR) in the assessment and management of patients with mitral regurgitation?
What is the role of Cardiovascular Magnetic Resonance (CMR) in the assessment and management of patients with mitral regurgitation?
This review highlights CMR as a robust, gold-standard imaging modality for accurately assessing cardiac and regurgitant volumes in patients with mitral regurgitation, complementing traditional echocardiography.
Cardiac magnetic resonance may complement echocardiography for mitral regurgitation assessment; extends review evidence but leaves open prospective outcome validation.
The 2019 Global Burden of Disease (GBD) study estimated that there were approximately 24.2 million people affected worldwide by degenerative mitral regurgitation (MR), resulting in 34,200 deaths. After aortic stenosis, MR is the most prevalent VHD in Europe and the second-most common VHD to pose indications for surgery in western countries. Current ESC and AHA/ACC guidelines for the management of VHD emphasize the importance of an integrative approach for the assessment of MR severity, which is of paramount importance in dictating the timing for surgery. Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are the first-line imaging modalities; however, despite the technological advancement, sometimes, the final diagnosis on the degree of the disease may still be challenging. In the last 20 years, CMR has emerged as a robust technique in the assessment of patients with cardiac disease, and, recently, its role is gaining more and more importance in the field of VHD. In fact, CMR is the gold standard in the assessment of cardiac volumes, and it is possible to accurately evaluate the regurgitant volume. The purpose of this review is to outline the current state-of-the-art management of MR by using Cardiac Magnetic Resonance (CMR).
No takes yet. Share an insight, caveat, or question.
Pavon et al. (2022) conducted a review in Mitral Regurgitation. Cardiac Magnetic Resonance (CMR) vs. Echocardiography was evaluated. Cardiac magnetic resonance provides an accurate and robust complementary imaging modality to echocardiography for grading mitral regurgitation severity, assessing ventricular volumes, and identifying myocardial fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: